Akanda (AKAN) Liabilities and Shareholders Equity (2020 - 2025)

Akanda's (AKAN) quarterly Liabilities and Shareholders Equity came in at $6.2 million in Q4 2025, down 21.71% year-on-year from $7.9 million in Q4 2024, and little changed quarter-over-quarter from $6.2 million in Q2 2025.

Akanda (AKAN) Liabilities and Shareholders Equity (2020 - 2025) Analysis & Trends

Akanda's Liabilities and Shareholders Equity history runs 6 years deep, the most recent figure standing at $6.2 million for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 21.71% year-over-year to $6.2 million in Q4 2025; TTM through Dec 2025 was $30.3 million, a 52.09% decrease from a year earlier, with the FY2025 full-year figure at $6.2 million, down 21.71% from the prior year.
  • Liabilities and Shareholders Equity was little changed at $6.2 million in Q4 2025 per AKAN's latest filing, from $6.2 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $43.5 million in Q2 2022 and bottomed at $6.2 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $8.8 million (2023), against an average of $18.5 million.
  • Across the five-year window, Liabilities and Shareholders Equity jumped 384.67% in 2022 and slumped 77.33% in 2023, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $8.0 million in 2021, then soared by 384.67% to $39.0 million in 2022, then slumped by 77.33% to $8.8 million in 2023, then dropped by 10.47% to $7.9 million in 2024, then dropped by 21.71% to $6.2 million in 2025.
  • Per Business Quant, the three latest AKAN Liabilities and Shareholders Equity figures stand at $6.2 million (Q4 2025), $6.2 million (Q2 2025), and $7.9 million (Q4 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Akanda 556,353.85 556,353.85 - 6.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 6.20 Mn
Jun 30, 2025 6.22 Mn
Dec 31, 2024 7.91 Mn
Jun 30, 2024 9.97 Mn
Dec 31, 2023 8.84 Mn
Jun 30, 2023 36.51 Mn
Dec 31, 2022 39.00 Mn
Jun 30, 2022 43.48 Mn
Dec 31, 2021 8.05 Mn
Dec 31, 2020 4.27 Mn